This inventor holds 1 USPTO granted patent. Top assignee: Sinil Pharmaceutical Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: **Mu Hong Lee: An Innovative Force in Pharmaceutical Development**
Introduction
Mu Hong Lee, a notable inventor based in Gyeonggi-do, South Korea, has made significant strides in the field of pharmaceutical compositions, focusing particularly on remedies for inflammatory diseases. With one patent to his name, Lee’s work promises to have a considerable impact on therapeutic practices.
Latest Patents
Mu Hong Lee holds a patent related to a pharmaceutical composition aimed at both the prevention and treatment of inflammatory diseases. This innovative composition includes a mix of herbal extracts and active ingredients, demonstrating superior therapeutic effects when compared to single herbal drugs. The patented formulation showcases efficacy in alleviating pain, reducing acute inflammation, and regulating enzyme secretion related to inflammation. Such advancements are especially beneficial for conditions like arthritis, broadening the scope of treatment possibilities.
Career Highlights
Lee is currently affiliated with Sinil Pharmaceutical Co., Ltd., where he contributes his expertise to enhance product development and innovation. His commitment to improving healthcare solutions is evident in his research and dedication to the pharmaceutical industry.
Collaborations
Throughout his career, Mu Hong Lee has had the opportunity to collaborate with other talented professionals in the field, including colleagues Jeong Min Lee and Chul Gyu Ha. These collaborations highlight the importance of teamwork and shared vision in achieving groundbreaking innovations in pharmaceuticals.
Conclusion
Mu Hong Lee’s contributions to the development of pharmaceutical compositions showcase the potential of combining herbal extracts to effectively combat inflammatory diseases. His ongoing work at Sinil Pharmaceutical Co., Ltd. and his collaborative efforts suggest a promising future for advancements in this vital area of medicine. Lee's innovative spirit undoubtedly inspires others in the field of pharmaceutical research and invention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile